KOREA PHARMA Market Cap

KOREA PHARMA has a market cap or net worth of 132.30 billion as of March 9, 2026. Its market cap has decreased by -21.49% in one year.

Market Cap

132.30B

Enterprise Value

137.11B

Revenue

90.11B

Ranking

n/a

PE Ratio

759.66

Stock Price

12,740.00

Market Cap Chart

Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 132.30B, a decrease of -28.01%. That is a compound annual growth rate of -5.72%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	132.30B	-6.69%
Dec 30, 2025	141.79B	-15.09%
Dec 30, 2024	166.98B	-35.26%
Dec 28, 2023	257.94B	10.51%
Dec 29, 2022	233.40B	-55.92%
Dec 30, 2021	529.52B	118.69%
Dec 30, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
DongKoo Bio & Pharma	145.49B
PHARMARESEARCH BIO	131.48B
Kyung Dong Pharmaceutical	148.18B
HYUNDAI BIOLAND	124.95B
High Tech Pharm	166.94B
WITHUS PHARMACEUTICAL Co.,LTD.	115.12B
GREEN CROSS WellBeing	168.05B
Pharos iBio	113.15B

Market Cap Rankings